These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 11944930)
1. Synthesis and characterization of N-coumaroyltyramine as a potent phytochemical which arrests human transformed cells via inhibiting protein tyrosine kinases. Park JB; Schoene N Biochem Biophys Res Commun; 2002 Apr; 292(4):1104-10. PubMed ID: 11944930 [TBL] [Abstract][Full Text] [Related]
2. N-Caffeoyltyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3. Park JB; Schoene N Cancer Lett; 2003 Dec; 202(2):161-71. PubMed ID: 14643446 [TBL] [Abstract][Full Text] [Related]
3. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466 [TBL] [Abstract][Full Text] [Related]
4. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Lee LT; Huang YT; Hwang JJ; Lee PP; Ke FC; Nair MP; Kanadaswam C; Lee MT Anticancer Res; 2002; 22(3):1615-27. PubMed ID: 12168845 [TBL] [Abstract][Full Text] [Related]
5. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Song L; Turkson J; Karras JG; Jove R; Haura EB Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138 [TBL] [Abstract][Full Text] [Related]
6. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown. Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867 [TBL] [Abstract][Full Text] [Related]
7. Screening enzyme-inhibitory activity in several ascidian species from Orkney Islands using protein tyrosine kinase (PTK) bioassay-guided fractionation. Barenbrock JS; Köck M J Biotechnol; 2005 May; 117(3):225-32. PubMed ID: 15862352 [TBL] [Abstract][Full Text] [Related]
8. K vitamins, PTP antagonism, and cell growth arrest. Carr BI; Wang Z; Kar S J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979 [TBL] [Abstract][Full Text] [Related]
9. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Liu Y; Poon RT; Shao W; Sun X; Chen H; Kok TW; Fan ST Cancer Lett; 2007 Apr; 248(1):32-40. PubMed ID: 16837130 [TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of N-feruloyltyramine as the P-selectin expression suppressor from garlic (Allium sativum). Park JB J Agric Food Chem; 2009 Oct; 57(19):8868-72. PubMed ID: 19807156 [TBL] [Abstract][Full Text] [Related]
11. Erkitinib, a novel EGFR tyrosine kinase inhibitor screened using a ProteoChip system from a phytochemical library. Kim EY; Choi YJ; Park CW; Kang IC Biochem Biophys Res Commun; 2009 Nov; 389(3):415-9. PubMed ID: 19716804 [TBL] [Abstract][Full Text] [Related]
12. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase. Forsberg S; Ostman A; Rollman O Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution. Rao YK; Fang SH; Tzeng YM Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849 [TBL] [Abstract][Full Text] [Related]
14. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41. Matheson SL; McNamee JP; Jean-Claude BJ Cancer Chemother Pharmacol; 2003 Jan; 51(1):11-20. PubMed ID: 12497201 [TBL] [Abstract][Full Text] [Related]
15. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578 [TBL] [Abstract][Full Text] [Related]
16. Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Cheng Y; Qiu F; Ye YC; Tashiro S; Onodera S; Ikejima T Arch Biochem Biophys; 2009 Oct; 490(1):70-5. PubMed ID: 19699177 [TBL] [Abstract][Full Text] [Related]
17. In vitro actions on human cancer cells and the liquid chromatography-mass spectrometry/mass spectrometry fingerprint of phytochemicals in rice protein isolate. Yu S; Fang N; Li Q; Zhang J; Luo H; Ronis M; Badger TM J Agric Food Chem; 2006 Jun; 54(12):4482-92. PubMed ID: 16756384 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4-ones. Xiao ZP; Li HQ; Shi L; Lv PC; Song ZC; Zhu HL ChemMedChem; 2008 Jul; 3(7):1077-82. PubMed ID: 18433075 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Rabindran SK; Discafani CM; Rosfjord EC; Baxter M; Floyd MB; Golas J; Hallett WA; Johnson BD; Nilakantan R; Overbeek E; Reich MF; Shen R; Shi X; Tsou HR; Wang YF; Wissner A Cancer Res; 2004 Jun; 64(11):3958-65. PubMed ID: 15173008 [TBL] [Abstract][Full Text] [Related]